Manager TitleAgeSince
Chief Operating Officer 67 2005-12-31
Chief Executive Officer 73 -
Chief Executive Officer 50 2023-12-28
Director TitleAgeSince
Chairman 73 2024-12-15
Director/Board Member 67 2005-12-31
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
-12.13%-36.36% - - 1.4M
-1.34%-3.09%+56.10%+68.83% 66.37B
+0.59%-1.83%+8.98%+90.01% 58.86B
+0.54%+0.45%+25.96%+87.77% 55.22B
-2.34%-3.90%+10.90%+115.97% 47.21B
+0.09%-6.08%+18.67%+25.90% 42.45B
-2.58%+0.24%+18.54%+41.28% 36.44B
-1.76%-11.56%+126.44%+649.27% 35.19B
-0.17%-1.83%+82.46%+57.69% 32.66B
-1.69%-0.79%-40.58%+382.68% 26.73B
Average -2.08%-3.93%+34.16%+168.82% 45B
Weighted average by Cap. -0.84%-3.64%+34.22%+143.97%
Logo 2cureX AB
2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.
Employees
14
  1. Stock Market
  2. Stocks
  3. 2CUREX Stock